Your location:HOME- NEWS- Industry dynamics

The new version of the basic drug issue will be faced with a big reshuffle
2018-09-11 17:57:42

Recently, the general office of the state council issued the opinions of the general office of the state council on improving the national basic drug system (hereinafter referred to as the opinions), which is the most important basic drug policy since the consensus evaluation of 289 oral basic drugs.










<p style="padding: 0px; margin: 0px; font-size: 17px; font-family: -apple-system-font, BlinkMacSystemFont, " helvetica="" neue",="" "pingfang="" sc",="" "hiragino="" sans="" gb",="" "microsoft="" yahei="" ui",="" yahei",="" arial,="" sans-serif;="" color:="" rgb(51,="" 51,="" 51);="" list-style-type:="" none;="" line-height:="" 1.75em;="" max-width:="" 100%;="" clear:="" both;="" min-height:="" 1em;="" letter-spacing:="" 0.544px;="" text-align:="" justify;="" box-sizing:="" border-box="" !important;="" word-wrap:="" break-word="" !important;"="">It can be seen that after the implementation of the new policy of base drugs, China's base drugs market is facing adjustment and a major reshuffle.

last:The scale of China's anticancer drug market is expanding